Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.
about
The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brainCD4+CD28- costimulation-independent T cells in multiple sclerosisThe voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MSmiRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencingAntigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune DiseasesPotassium channels, memory T cells, and multiple sclerosisTargeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseasesAutoimmune T cell responses in the central nervous systemCytomegalovirus infection exacerbates autoimmune mediated neuroinflammation.Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System.Peripheral and site-specific CD4(+) CD28(null) T cells from rheumatoid arthritis patients show distinct characteristics.Antiviral immune responses: triggers of or triggered by autoimmunity?Autoimmune effector memory T cells: the bad and the goodDeveloping antigen-specific therapies in multiple sclerosis: a tale of Tantalus or Ulysses?A novel fluorescent toxin to detect and investigate Kv1.3 channel up-regulation in chronically activated T lymphocytes.Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity.Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.4-1BB enhances proliferation of beryllium-specific T cells in the lung of subjects with chronic beryllium diseaseMemory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein.Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosisGAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes.The therapeutic potential of HDAC inhibitors in the treatment of multiple sclerosisIncreased frequencies of myelin oligodendrocyte glycoprotein/MHC class II-binding CD4 cells in patients with multiple sclerosis.Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies.Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720.Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy.CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cellsImmunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitisThe initiation and prevention of multiple sclerosis.N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.Multiparameter Flow Cytometric Assays to Quantify Effector and Regulatory T-Cell Function in Multiple SclerosisAutoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.Antigenic Stimulation of Kv1.3-Deficient Th Cells Gives Rise to a Population of Foxp3-Independent T Cells with Suppressive Properties.Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseasesmiR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis.Allelic variant in CTLA4 alters T cell phosphorylation patternsTGF-β signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAEDistinct functions of autoreactive memory and effector CD4+ T cells in experimental autoimmune encephalomyelitis.Memory cells specific for myelin oligodendrocyte glycoprotein (MOG) govern the transfer of experimental autoimmune encephalomyelitis
P2860
Q24534346-CC7D1218-52BB-4D23-ADAC-9A9576977805Q24670063-DEC0B929-3013-45ED-84B4-9724917FDDA4Q24675746-4B1489B9-37B1-4BF4-8B94-3A942FD2A90AQ26852074-5168C037-022E-4DCD-A21C-FE1BABA2DBFCQ28080791-05587EE0-E0F3-43BD-9E13-5DB8D02A355FQ28281365-887C56A5-05FB-4484-BB00-7B58C365B636Q28303760-7CABE1B3-739B-428D-BF4E-DD002903F767Q33620003-3847558A-1B62-4994-A5D9-A03B10A01C8DQ33673956-31F37022-EC48-4C56-8A30-9F51C7E0F99EQ33687644-C4357878-8872-45A2-A2A9-642A314B2310Q33770508-C0C51788-6767-4AF4-AE82-F5D08F5B7EFBQ33782717-2BD92550-05FD-49D8-9E3B-55C3EC03DBF8Q33789445-F1BF797B-72EB-43FD-A85A-765637026B55Q33794691-450F7453-206C-40C8-A05E-E42257D9AA86Q34119484-D189F672-5FC7-4209-B9E1-F97F12A16BEAQ34168371-47F78D13-8C22-4A00-8D19-E0EF821E82DAQ34233085-12898B37-6131-4CE1-BDDD-FEFFD7CFA70CQ34311395-675D736E-1E9A-4953-B0A9-C72D70EB3BB7Q34670370-66E176F2-304A-47BA-90C7-66A5BE098555Q34773444-FBED056B-9309-4655-A30B-0ADB05AC675CQ34789216-7FC0E36D-A38B-478B-9630-2A9E137A9A21Q34790295-E731E8A1-D093-4618-BC38-866BB624ECB5Q35016997-2096E20F-F1F4-4DA1-AD70-B0DECC2E155AQ35091432-D5CD57FA-530E-48A3-95E7-3AE29730FD5FQ35094706-63A65399-2C02-4356-8596-34D078EAE20EQ35572346-A7CA95D7-383C-4256-B885-E61988E85263Q35613048-0D405E8C-49B9-457C-B352-903161F10B8FQ35679137-460727F8-E488-4F98-BC1C-585DE4CF4EE4Q35689857-CCC7AF7D-4549-4733-BB0A-31C2296E337DQ35741861-4C87D4C8-4B69-426E-B464-3D19470E9045Q35756367-9CC8D336-C857-4DF2-9F63-8D7DAD1E1D9DQ35794340-F53690E5-E78F-4BB0-8B82-9044D006EF51Q35861182-A1003183-3E5D-4C37-BA57-482082F558BEQ35931778-7B3C0254-EE02-4F65-9D66-CD69BCA6CD9EQ36097325-FD94CF7C-4274-436B-8F49-0C8CEB8EEFAEQ36139956-21C2B2D2-37CA-4936-BC3C-3D9FCCA49A86Q36276908-81FD44C6-1732-4D76-8704-91F058A7F5AFQ36340416-3EA79C3A-7A5E-4A20-A3B6-46C116190815Q36778241-C0C7B262-2FDC-4C50-9577-E73BB25382B2Q36949340-7645CD09-4EA1-4A3C-ADC2-9CD7EDDCBD6E
P2860
Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Decreased dependence of myelin ...... r of activated/memory T cells.
@en
Decreased dependence of myelin ...... r of activated/memory T cells.
@nl
type
label
Decreased dependence of myelin ...... r of activated/memory T cells.
@en
Decreased dependence of myelin ...... r of activated/memory T cells.
@nl
prefLabel
Decreased dependence of myelin ...... r of activated/memory T cells.
@en
Decreased dependence of myelin ...... r of activated/memory T cells.
@nl
P2093
P2860
P356
P1476
Decreased dependence of myelin ...... r of activated/memory T cells.
@en
P2093
A E Lovett-Racke
J L Trotter
P J Perrin
P2860
P304
P356
10.1172/JCI1528
P407
P577
1998-02-01T00:00:00Z